Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : NIFTY NINE IN NINETY NINE PLUS ONE -- Ignore unavailable to you. Want to Upgrade?

To: Mike McFarland who wrote (350)	2/2/1999 5:40:00 PM
From: Steve Lokness	Respond to of 613

Mike; Please give us your thoughts on GLGC after going through the information. Unless todays news regarding CLPA unblinding involved fraud - which I do not believe - doesn't the news reenforce the business strategy of GLGC and others like it? Pharmacogenomics can perhaps tell why certain test fail or why some patients may respond while others do not. Watch for news release today for Axys if you are interested/believe in pharmacogenomics. This company is very well put together! Steve

To: Mike McFarland who wrote (350)	2/2/1999 8:20:00 PM
From: Arthur Radley	Respond to of 613

Mike, I would also be interested in your review of GLGC info. The stock seems to be stagnated at the current levels.